108 results
Page 4 of 6
8-K
EX-99.1
dd4xmj
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
gd245p3hk hdw
31 Oct 19
Other Events
10:10am
8-K
EX-99.2
aonc 0h2da
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
26tf8qq
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
sj16z rk8tjuyh2kk
20 May 19
Other Events
8:52am
8-K
EX-99.1
wmrnqo7
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
tq3b255
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
7hg4bz4m2xk
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.2
0vhg rkxk5e
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
6k51jc1nbrvki
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
a27mh2e
7 Jan 19
Other Events
7:01am
8-K
EX-99.1
l5l 17at7rulrb
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
zxwth ynu5
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.2
tsawkjsvw6w2gcx6a
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
c3afa5ecbthp4p6x7sik
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am